Pricing

Clinical Data, Inc. (New) (CLDA)

followers ·
Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
LABORATORY ANALYTICAL INSTRUMENTS
ONE GATEWAY CENTER NEWTON, MA 02458

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • Novitron International Inc.
Stock Split History
DateRatio
2002-09-11 1.2500
2007-10-02 3:2
Clinical Data, through its main operating business, PGxHealth, LLC, is focused on the development and commercialization of novel therapeutics, with two lead compounds in the areas of central nervous system and cardiovascular disorders. Co.'s lead drug candidate is vilazodone, for the treatment of depression. Co.'s second late-stage drug candidate is apadenoson, trademarked Stedivaze, for use as a pharmacologic stress agent in nuclear-Single Photo Emission Computed Topography myocardial perfusion imaging. Co. also provides the FAMILION family of genetic tests for inherited cardiac syndromes, including cardiac channelopathies and cardiomyopathies.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available